Skip to content
Home » News » ‘Breakthrough’ Alzheimer’s drugs unlikely to benefit patients, report suggests

‘Breakthrough’ Alzheimer’s drugs unlikely to benefit patients, report suggests

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed. Read More